Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Parashar UD, Alexander JP, Glass RI; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2006 Aug 11;55(RR-12):1-13.

2.

Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Cortese MM, Parashar UD; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2009 Feb 6;58(RR-2):1-25. Erratum in: MMWR Recomm Rep. 2010 Aug 27;59(33):1074.

3.

Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.

American Academy of Pediatrics Committee on Infectious Diseases.

Pediatrics. 2007 Jan;119(1):171-82.

PMID:
17200286
5.

Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007.

Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Morb Mortal Wkly Rep. 2008 Apr 18;57(15):398-401.

6.

Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.

Plosker GL.

Drugs. 2010 Jun 18;70(9):1165-88. doi: 10.2165/11205030-000000000-00000. Review.

PMID:
20518582
7.

Spotlight on pentavalent rotavirus vaccine (RotaTeq) in the prevention of rotavirus gastroenteritis in Europe.

Plosker GL.

BioDrugs. 2010 Dec 1;24(6):411-4. doi: 10.2165/11205070-000000000-00000.

PMID:
21043548
8.

Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine.

Committee on Infectious Diseases; American Academy of Pediatrics.

Pediatrics. 2009 May;123(5):1412-20. doi: 10.1542/peds.2009-0466. Epub 2009 Mar 30.

PMID:
19332437
9.

Rotavirus vaccine: a cost effective control measure for India.

Kumar A, Goel MK, Jain RB, Khanna P, Vibha V.

Hum Vaccin Immunother. 2012 Apr;8(4):501-4. Review.

PMID:
23071989
10.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
11.

RotaTeq for prevention of rotavirus gastroenteritis.

Laustsen G.

Nurse Pract. 2006 Aug;31(8):54-5. No abstract available.

PMID:
16966977
12.

Rotavirus vaccines.

Vesikari T.

Scand J Infect Dis. 2008;40(9):691-5. Review.

PMID:
19086243
13.

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.

Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, Le HT, Coia ML, Lewis K, Rivers SB, Sack DA, Schödel F, Steele AD, Neuzil KM, Ciarlet M.

Lancet. 2010 Aug 21;376(9741):615-23. doi: 10.1016/S0140-6736(10)60755-6. Epub 2010 Aug 6.

PMID:
20692031
14.

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.

Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy and Safety Trial (REST) Study Team.

N Engl J Med. 2006 Jan 5;354(1):23-33.

15.
16.
17.

Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Mar 16;56(10):218-22.

18.

Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America.

Tregnaghi MW, Abate HJ, Valencia A, Lopez P, Da Silveira TR, Rivera L, Rivera Medina DM, Saez-Llorens X, Gonzalez Ayala SE, De León T, Van Doorn LJ, Pilar Rubio MD, Suryakiran PV, Casellas JM, Ortega-Barria E, Smolenov IV, Han HH; Rota-024 Study Group.

Pediatr Infect Dis J. 2011 Jun;30(6):e103-8. doi: 10.1097/INF.0b013e3182138278.

PMID:
21378594
19.

Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.

Omenaca F, Sarlangue J, Szenborn L, Nogueira M, Suryakiran PV, Smolenov IV, Han HH; ROTA-054 Study Group.

Pediatr Infect Dis J. 2012 May;31(5):487-93. doi: 10.1097/INF.0b013e3182490a2c.

PMID:
22228231
20.

[Rotavirus Vaccine. Statement of the Consultive Committee of Immunizations on behalf of The Chilean Infectious Diseases Society. March 2006].

Muñoz M A, Abarca V K, Luchsinger F V, Valenzuela B MT, Jiménez de la J J; Comité Consultivo de Inmunizaciones, Sociedad Chilena de Infectología.

Rev Chilena Infectol. 2006 Jun;23(2):124-7. Epub 2006 May 16. Review. Spanish.

Supplemental Content

Support Center